Valar Labs is a California-based precision medicine company focusing on developing innovative computational histology AI tests that can predict patients' responses to cancer therapies. These tests allow physicians and patients to choose the best treatment based on tumor biology. Founded in 2021 with headquarters in Palo Alto, the company recently launched the first-ever AI-based oncology test, Vesta, to empower physicians with new capabilities.